These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37944670)

  • 1. The value of point-of-care tests for the detection of SARS-CoV-2 RNA or antigen in bronchoalveolar lavage fluid.
    Van Slambrouck J; Schoenaers C; Laenen L; Jin X; Beuselinck K; Verdonck A; Wauters J; Molenberghs G; Vanaudenaerde BM; Vos R; Mombaerts P; Lagrou K; Ceulemans LJ
    J Virol Methods; 2024 Jan; 323():114848. PubMed ID: 37944670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Deeks JJ; Adriano A; Berhane S; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; Spijker R; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013705. PubMed ID: 32845525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid and Safe Detection of SARS-CoV-2 and Influenza Virus RNA Using Onsite Quantitative PCR Diagnostic Testing From Clinical Specimens Collected in Molecular Transport Medium.
    Daum LT; Fischer GW
    J Appl Lab Med; 2021 Nov; 6(6):1409-1416. PubMed ID: 34156459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Detection on Bronchoalveolar Lavage: An Italian Multicenter experience.
    Patrucco F; Albera C; Bellocchia M; Foci V; Gavelli F; Castello LM; Bellan M; Sainaghi PP; Airoldi C; Balbo PE; Solidoro P
    Respiration; 2020; 99(11):970-978. PubMed ID: 33075793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-market surveillance of six COVID-19 point-of-care tests using pre-Omicron and Omicron SARS-CoV-2 variants.
    Exner HM; Gregorchuk BSJ; Castor A-G; Crisostomo L; Kolsun K; Giesbrecht S; Dust K; Alexander DC; Bolaji A; Quill Z; Head BM; Meyers AFA; Sandstrom P; Becker MG
    Microbiol Spectr; 2024 Jul; 12(7):e0016324. PubMed ID: 38757955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Performance of the Point-of-Care cobas Liat for Detection of SARS-CoV-2 in 20 Minutes: a Multicenter Study.
    Hansen G; Marino J; Wang ZX; Beavis KG; Rodrigo J; Labog K; Westblade LF; Jin R; Love N; Ding K; Garg S; Huang A; Sickler J; Tran NK
    J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33239382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of two rapid point of care SARS-COV-2 antibody assays against laboratory-based automated chemiluminescent immunoassays for SARS-COV-2 IG-G, IG-M and total antibodies.
    Lau CS; Hoo SP; Liang YL; Phua SK; Aw TC
    Pract Lab Med; 2021 Mar; 24():e00201. PubMed ID: 33501369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avoiding False-Positive SARS-CoV-2 Rapid Antigen Test Results with Point-of-Care Molecular Testing on Residual Test Buffer.
    LeBlanc JJ; McCracken GR; Goodall B; Hatchette TF; Barrett L; Ross J; Davidson RJ; Patriquin G
    Microbiol Spectr; 2022 Aug; 10(4):e0063922. PubMed ID: 35863036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy comparison of three rapid antigen tests for SARS-CoV-2 and how viral load impact their performance.
    Blairon L; Cupaiolo R; Thomas I; Piteüs S; Wilmet A; Beukinga I; Tré-Hardy M
    J Med Virol; 2021 Oct; 93(10):5783-5788. PubMed ID: 34050945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitive tracking of circulating viral RNA through all stages of SARS-CoV-2 infection.
    Huang Z; Ning B; Yang HS; Youngquist BM; Niu A; Lyon CJ; Beddingfield BJ; Fears AC; Monk CH; Murrell AE; Bilton SJ; Linhuber JP; Norton EB; Dietrich ML; Yee J; Lai W; Scott JW; Yin XM; Rappaport J; Robinson JE; Saba NS; Roy CJ; Zwezdaryk KJ; Zhao Z; Hu TY
    J Clin Invest; 2021 Apr; 131(7):. PubMed ID: 33561010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical and Clinical Analysis of Two Automated Anti-SARS-CoV-2 Immunoassays in Pre-Pandemic and Pandemic Patient Populations.
    Yang J; Pederson EC; Hamilton C; Neibauer T; Robyak K; McGhee P; Speicher T; Zhu Y
    J Appl Lab Med; 2021 Mar; 6(2):441-450. PubMed ID: 33152084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Performance of the cobas Liat SARS-CoV-2 & Influenza A/B Assay in Nasal Samples.
    Akashi Y; Horie M; Kiyotaki J; Takeuchi Y; Togashi K; Adachi Y; Ueda A; Notake S; Nakamura K; Terada N; Kurihara Y; Kiyasu Y; Suzuki H
    Mol Diagn Ther; 2022 May; 26(3):323-331. PubMed ID: 35391608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the Rapid Antigen Detection Kit with the Polymerase Chain Reaction for Detection of SARS-CoV-2 in Respiratory Samples].
    Erman Daloğlu A; Er H; Sepin Özen N; Çekin Y
    Mikrobiyol Bul; 2022 Apr; 56(2):263-273. PubMed ID: 35477229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of six different rapid methods for nucleic acid detection of SARS-COV-2 virus.
    Mahmoud SA; Ganesan S; Ibrahim E; Thakre B; Teddy JG; Raheja P; Zaher WA
    J Med Virol; 2021 Sep; 93(9):5538-5543. PubMed ID: 34002401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid diagnosis of SARS-CoV-2 pneumonia on lower respiratory tract specimens.
    De Pace V; Caligiuri P; Ricucci V; Nigro N; Galano B; Visconti V; Da Rin G; Bruzzone B
    BMC Infect Dis; 2021 Sep; 21(1):926. PubMed ID: 34493222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 rapid antigen test: High sensitivity to detect infectious virus.
    Nordgren J; Sharma S; Olsson H; Jämtberg M; Falkeborn T; Svensson L; Hagbom M
    J Clin Virol; 2021 Jul; 140():104846. PubMed ID: 33971580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of an antigen-based test for hospital point-of-care diagnosis of SARS-CoV-2 infection.
    Bianco G; Boattini M; Barbui AM; Scozzari G; Riccardini F; Coggiola M; Lupia E; Cavallo R; Costa C
    J Clin Virol; 2021 Jun; 139():104838. PubMed ID: 33946040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.